InnaVirVax

About:

InnaVirVax develops therapeutics, diagnostics, prevention aids, and prognostics for HIV, infectious diseases, and cancers.

Website: http://www.innavirvax.fr

Top Investors: Karista

Description:

InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.

Total Funding Amount:

$12.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Évry, Ile-de-France, France

Founded Date:

2008-01-01

Contact Email:

contact(AT)innavirvax.fr

Founders:

Patrice Debre

Number of Employees:

11-50

Last Funding Date:

2015-07-17

IPO Status:

Private

Industries: